Tweet
The Lancet, Volume 376, Issue 9758, Page 2116, 18 December 2010
<Previous Article
doi:10.1016/S0140-6736(10)61345-1Cite or Link Using DOI
Cytotoxic therapy for severe swine flu A/H1N1
Original Text
Prof Jan-Inge Henter MD a Corresponding AuthorEmail Address, Kajsa Palmkvist-Kaijser MD a, Bernhard Holzgraefe MD b, Yenan T Bryceson PhD c, Kenneth Palm?r MD b
In November, 2009, a 31-year-old man presented with fever (40?3?C) and severe dyspnoea. Broad-spectrum antibiotics, and antiviral treatment with oseltamivir, were initiated. PCR confirmed infection with a novel swine-origin influenza A (H1N1) virus. Mechanical ventilation was started 3 days after admission, and veno-arterial extracorporeal membrane oxygenation (ECMO) 8 days later, because of refractory respiratory and circulatory failure. He developed multiple pneumatoceles, recurrent pneumothor ...
<Previous Article
doi:10.1016/S0140-6736(10)61345-1Cite or Link Using DOI
Cytotoxic therapy for severe swine flu A/H1N1
Original Text
Prof Jan-Inge Henter MD a Corresponding AuthorEmail Address, Kajsa Palmkvist-Kaijser MD a, Bernhard Holzgraefe MD b, Yenan T Bryceson PhD c, Kenneth Palm?r MD b
In November, 2009, a 31-year-old man presented with fever (40?3?C) and severe dyspnoea. Broad-spectrum antibiotics, and antiviral treatment with oseltamivir, were initiated. PCR confirmed infection with a novel swine-origin influenza A (H1N1) virus. Mechanical ventilation was started 3 days after admission, and veno-arterial extracorporeal membrane oxygenation (ECMO) 8 days later, because of refractory respiratory and circulatory failure. He developed multiple pneumatoceles, recurrent pneumothor ...
